LIM
TEVA icon

Loudon Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Loudon Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-61,639
Closed -$2.05M – 88
2017
Q2 		$2.05M Sell
61,639
-24,070
-28% -$745K 1.55% 24
2017
Q1 		$2.75M Buy
85,709
+435
+0.5% +$14.8K 2.09% 16
2016
Q4 		$3.09M Sell
85,274
-2,065
-2% -$82.4K 2.41% 11
2016
Q3 		$4.02M Buy
87,339
+150
+0.2% +$7.83K 3.12% 9
2016
Q2 		$4.38M Sell
87,189
-396
-0.5% -$21.1K 3.49% 7
2016
Q1 		$4.69M Sell
87,585
-4,317
-5% -$253K 3.77% 8
2015
Q4 		$6.03M Sell
91,902
-1,047
-1% -$64.7K 4.85% 2
2015
Q3 		$5.25M Sell
92,949
-6,825
-7% -$443K 4.51% 2
2015
Q2 		$5.9M Sell
99,774
-6,550
-6% -$404K 4.47% 2
2015
Q1 		$6.62M Sell
106,324
-5,005
-4% -$291K 5.02% 2
2014
Q4 		$6.4M Sell
111,329
-3,300
-3% -$184K 4.79% 5
2014
Q3 		$6.16M Sell
114,629
-1,705
-1% -$90.3K 4.39% 4
2014
Q2 		$6.1M Sell
116,334
-1,065
-0.9% -$54.4K 4.19% 4
2014
Q1 		$6.2M Buy
117,399
+2,950
+3% +$136K 4.48% 4
2013
Q4 		$4.59M Buy
+114,449
New +$4.51M 3.37% 7

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loudon Investment Management's TEVA Position: Q3 2017 in Review

Loudon Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 61,639 shares — an estimated $2.05M sold.

Loudon Investment Management first reported a position in TEVA in Q4 2013 and held it in 15 quarters. The position peaked at $6.62M in Q1 2015. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Loudon Investment Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Loudon Investment Management sold 61,639 Teva Pharmaceuticals shares in Q3 2017, an estimated $2.05M.
  • Loudon Investment Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 15 quarters.
  • Loudon Investment Management's Teva Pharmaceuticals position peaked at $6.62M in Q1 2015.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Loudon Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.